Carboplatin plus weekly paclitaxel treatment in non-small cell lung cancer patients with interstitial lung disease.
Shukuya
T
T
Department of Respiratory Medicine, Juntendo University, School of Medicine, Bunkyou-ku, Tokyo, Japan. tshukuya@juntendo.ac.jp
Ishiwata
T
T
Hara
M
M
Muraki
K
K
Shibayama
R
R
Koyama
R
R
Takahashi
K
K
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000009:adverse effects; D016190:Carboplatin / Q000008:administration & dosage / Q000009:adverse effects; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000473:pathology; D015331:Cohort Studies; D018572:Disease-Free Survival; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000188:drug therapy* / Q000473:pathology; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D017239:Paclitaxel / Q000008:administration & dosage / Q000009:adverse effects; D010349:Patient Compliance; D012189:Retrospective Studies
D016190:Carboplatin; D017239:Paclitaxel